|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| A61K 9/1635 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/1682 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 9/4833 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3597179 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19181217.1 |
| Date of filing the European patent application | 2014-12-11 | |
| (97) | Date of publication of the European application | 2020-01-22 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361915606 P | 2013-12-13 | US |
| (72) |
RIBEIRO, Suzie , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL DOSAGE FORMS |
| PHARMACEUTICAL DOSAGE FORMS |